Ingmar Mederacke

6.8k total citations · 5 hit papers
46 papers, 4.6k citations indexed

About

Ingmar Mederacke is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ingmar Mederacke has authored 46 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 32 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Ingmar Mederacke's work include Liver Disease Diagnosis and Treatment (30 papers), Hepatitis C virus research (17 papers) and Hepatitis B Virus Studies (15 papers). Ingmar Mederacke is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Hepatitis C virus research (17 papers) and Hepatitis B Virus Studies (15 papers). Ingmar Mederacke collaborates with scholars based in Germany, United States and Türkiye. Ingmar Mederacke's co-authors include Robert F. Schwabe, Dianne H. Dapito, Jean‐Philippe Pradère, Xueru Mu, Juliane S. Troeger, Christine Hsu, Geum‐Youn Gwak, Richard A. Friedman, Peter Huebener and Heiner Wedemeyer and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Gastroenterology.

In The Last Decade

Ingmar Mederacke

43 papers receiving 4.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

2013 1.0k citations Ingmar Mederacke, Christine Hsu et al. profile →
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

2012 999 citations Dianne H. Dapito, Geum‐Youn Gwak et al. profile →
Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice

2013 482 citations Jean‐Philippe Pradère, Geum‐Youn Gwak et al. Hepatology profile →
High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers

2015 407 citations Ingmar Mederacke, Dianne H. Dapito et al. Nature Protocols profile →
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice

2012 392 citations Juliane S. Troeger, Ingmar Mederacke et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingmar Mederacke Germany	23	2.7k	2.6k	1.2k	776	564	46	4.6k
Dianne H. Dapito United States	17	2.2k 0.8×	2.0k 0.8×	1.3k 1.1×	769 1.0×	735 1.3×	18	4.3k
Hermann E. Wasmuth Germany	38	2.3k 0.8×	2.3k 0.9×	701 0.6×	656 0.8×	941 1.7×	81	4.3k
Mitsuhiko Moriyama Japan	30	2.7k 1.0×	2.9k 1.1×	689 0.6×	549 0.7×	243 0.4×	221	4.9k
Hiromi Ishibashi Japan	43	3.3k 1.2×	3.8k 1.5×	1.1k 0.9×	1.6k 2.1×	1.1k 1.9×	234	6.7k
Felix Heymann Germany	31	2.1k 0.8×	1.7k 0.6×	1.1k 0.9×	638 0.8×	2.1k 3.6×	54	5.3k
Maria Lorena Abate Italy	31	3.2k 1.2×	3.1k 1.2×	688 0.6×	302 0.4×	400 0.7×	99	4.8k
Konrad L. Streetz Germany	34	1.6k 0.6×	1.4k 0.5×	2.5k 2.1×	697 0.9×	827 1.5×	77	5.2k
Simon C. Afford United Kingdom	36	1.1k 0.4×	1.9k 0.7×	1.0k 0.9×	1.6k 2.1×	1.1k 1.9×	114	4.6k
Hans‐Peter Dienes Germany	31	2.2k 0.8×	2.3k 0.9×	795 0.7×	753 1.0×	479 0.8×	57	4.0k
Oliver Waidmann Germany	32	1.6k 0.6×	848 0.3×	1.7k 1.4×	487 0.6×	565 1.0×	116	4.1k

Countries citing papers authored by Ingmar Mederacke

Since Specialization

Citations

This map shows the geographic impact of Ingmar Mederacke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Mederacke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Mederacke more than expected).

Fields of papers citing papers by Ingmar Mederacke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingmar Mederacke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Mederacke. The network helps show where Ingmar Mederacke may publish in the future.

Co-authorship network of co-authors of Ingmar Mederacke

This figure shows the co-authorship network connecting the top 25 collaborators of Ingmar Mederacke. A scholar is included among the top collaborators of Ingmar Mederacke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingmar Mederacke. Ingmar Mederacke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mederacke, Ingmar, et al.. (2023). An inducible model for genetic manipulation and fate-tracing of PDGFRβ-expressing fibrogenic cells in the liver. Scientific Reports. 13(1). 7322–7322. 3 indexed citations

Legchenko, Ekaterina, Philippe Chouvarine, Richard Taubert, et al.. (2022). Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis. Frontiers in Cardiovascular Medicine. 9. 862330–862330. 6 indexed citations

Janssen, C., et al.. (2020). Massivste epigastrische Schmerzen bei einem 59-jährigen Patienten. Der Internist. 62(2). 207–211.

Bräsen, Jan Hinrich, Jessica Schmitz, Björn Hartleben, et al.. (2019). Cholemic Nephropathy Causes Acute Kidney Injury and Is Accompanied by Loss of Aquaporin 2 in Collecting Ducts. Hepatology. 69(5). 2107–2119. 41 indexed citations

Suk, Ki Tae, Ingmar Mederacke, Geum‐Youn Gwak, et al.. (2016). Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis. Gut. 65(10). 1721–1732. 32 indexed citations

Mederacke, Ingmar, Dianne H. Dapito, Silvia Affò, Hiroshi Uchinami, & Robert F. Schwabe. (2015). High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nature Protocols. 10(2). 305–315. 407 indexed citations breakdown →

Huebener, Peter, Geum‐Youn Gwak, Jean‐Philippe Pradère, et al.. (2014). High-Mobility Group Box 1 Is Dispensable for Autophagy, Mitochondrial Quality Control, and Organ Function In Vivo. Cell Metabolism. 19(3). 539–547. 63 indexed citations

Heidrich, Benjamin, Sven Pischke, Fabian Helfritz, et al.. (2013). Hepatitis C virus core antigen testing in liver and kidney transplant recipients. Journal of Viral Hepatitis. 21(11). 769–779. 22 indexed citations

Jaroszewicz, Jerzy, Jürgen K. Rockstroh, Dirk Meyer‐Olson, et al.. (2012). Improved Immune Status Corresponds with Long-Term Decline of Quantitative Serum Hepatitis B Surface Antigen in HBV/HIV Co-infected Patients. Viral Immunology. 25(6). 442–447. 12 indexed citations

10.

Troeger, Juliane S., Ingmar Mederacke, Geum‐Youn Gwak, et al.. (2012). Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice. Gastroenterology. 143(4). 1073–1083.e22. 392 indexed citations breakdown →

11.

Mederacke, Ingmar, Cihan Yurdaydın, Anika Großhennig, et al.. (2011). Renal function during treatment with adefovir plus peginterferon alfa‐2a vs either drug alone in hepatitis B/D co‐infection. Journal of Viral Hepatitis. 19(6). 387–395. 5 indexed citations

12.

Rifai, Kinan, Ingmar Mederacke, Mathias Bähr, et al.. (2011). Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). Digestive and Liver Disease. 43(6). 491–497. 113 indexed citations

13.

Mederacke, Ingmar, Natalie Filmann, Cihan Yurdaydın, et al.. (2011). Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation. Journal of Hepatology. 56(1). 115–122. 52 indexed citations

14.

Wursthorn, Karsten, Jerzy Jaroszewicz, R. Raupach, et al.. (2011). Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum. Journal of Clinical Virology. 50(4). 292–296. 72 indexed citations

15.

Mederacke, Ingmar, et al.. (2011). Simultaneous Mitral Valve Replacement and Liver Transplantation. The Thoracic and Cardiovascular Surgeon. 59(8). 506–508. 4 indexed citations

16.

Boozari, B, Andrej Potthoff, Ingmar Mederacke, et al.. (2010). Evaluation of Sound Speed for Detection of Liver Fibrosis. Journal of Ultrasound in Medicine. 29(11). 1581–1588. 32 indexed citations

17.

Mederacke, Ingmar, Sandra Ciesek, R. Raupach, et al.. (2009). 333 KINETICS OF HCV CORE ANTIGEN DURING ANTIVIRAL TREATMENT OF ACUTE AND CHRONIC HEPATITIS C AS DETERMINED BY A NOVEL CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY. Journal of Hepatology. 50. S129–S129. 3 indexed citations

18.

Mederacke, Ingmar, Heiner Wedemeyer, & Michael P. Manns. (2009). Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection.. PubMed. 10(2). 181–9. 36 indexed citations

19.

Mederacke, Ingmar & Heiner Wedemeyer. (2009). Nitazoxanide for the treatment of chronic hepatitis C New opportunities but new challenges?. Annals of Hepatology. 8(2). 166–168. 12 indexed citations

20.

Mederacke, Ingmar, Heiner Wedemeyer, Sandra Ciesek, et al.. (2009). Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. Journal of Clinical Virology. 46(3). 210–215. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact